Market Overview:
Respiratory inhalers are devices used to deliver medication directly to the airways to treat respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). The use of inhalers provides localized and faster relief compared to oral medications.

Market key trends:
There is a significant demand for smart respiratory inhalers which can provide real-time insights into the lung capacity and monitor medication compliance of patients. Smart inhalers are integrated with sensors and mobile applications to record whenever medication is released, track location and setting reminders to improve inhalation technique of patients. This allows physicians to monitor patients remotely and optimize therapy accordingly.
Here is the analysis for the given Respiratory Inhalers Market:

Segment Analysis
The global Respiratory Inhalers Market Demand is dominated by the metered-dose inhalers (MDIs) segment. MDIs are popular as they are cost-effective, portable, and easy to use as compared to other respiratory inhaler types. They are widely used for treating chronic obstructive pulmonary disease (COPD) and asthma. Dry powder inhalers (DPIs) are the second largest segment. DPIs are gaining popularity as they do not require coordination of actuation with inspiration. Moreover, certain DPIs can deliver higher doses of medications as compared to MDIs.

Key Takeaways
The global respiratory inhalers market is expected to witness high growth, exhibiting CAGR of 4.8% over the forecast period, due to increasing prevalence of chronic respiratory diseases such as asthma and COPD.

Regional analysis North America dominates the global respiratory inhalers market. This is attributed to high adoption of inhalers and presence of major players in countries like the US and Canada. Europe is the second largest market.

Key players operating in the respiratory inhalers market are AstraZeneca Plc, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, Cipla Ltd, GSK Plc, Koninklijke Philips NV, OMRON Corp, OPKO Health, Inc, PARI Respiratory Equipment, Inc., and Teva Pharmaceutical Industries Ltd.are the leading companies operating in the North America respiratory inhalers market.

Read More:

http://marketerefforts.weebly.com/home/respiratory-inhalers-market-estimated-to-witness-high-growth-owing-to-rising-prevalence-of-asthma-and-copd